Literature DB >> 33849623

The influence of TCM constitutions and neurocognitive function in elderly Macau individuals.

Zhuo Zhang1, Yaochen Chuang2,3, Xinyu Ke1, Ji Wang4, Youhua Xu2, Yonghua Zhao5, Ying Bian6.   

Abstract

BACKGROUND: Traditional Chinese medicine (TCM) constitution contributes to predicating disease occurrence and pathological progress. In this study, we investigate the correlation between TCM constitution and neurocognitive function in elderly Macau individuals.
METHODS: A total of 313 older adults from elderly healthcare centers were recruited at random. The data of gender, age, education, sleeping hours, physical activities were collected, and the Geriatric Depression Scale, Hong Kong version of the Montreal Cognitive Assessment (MoCA) and categories of TCM constitution were administered.
RESULTS: Of the 313 elderly individuals enrolled in this study, 86 (27.48%) were of balanced constitution. Among the other categories of TCM constitution, the most was Yin-deficiency (23.32%), followed by 53 (16.93%) with Phlegm-dampness. The average neurocognitive score of all elderly individuals was 18.01 ± 6.25. After adjusting for all possible confounds, multiple linear regression analysis showed that Qi-depressed constitution and neurocognitive scores were negatively correlated (β = - 2.66, 95%CI - 4.99 ~ - 0.33), Meanwhile, Yin-deficient constitution and neurocognitive scores were negatively correlated (β = - 2.10, 95%CI - 3.73 ~ - 0.47). Compared with balanced constitution, Qi-depressed constitution mainly affected visual-spatial ability dimension (β = - 0.91, 95%CI - 1.54 ~ - 0.28) and naming dimension (β = - 0.64, 95%CI - 1.04 ~ - 0.25), Yin-deficient constitution mainly affected visual space dimension (β = - 0.53, 95%CI - 0.97 ~ - 0.08).
CONCLUSION: Qi-depressed and Yin-deficient constitutions are associated with and contributed to the decline of neurocognitive function in senior adults, especially visual-spatial ability and naming dimensions. Further investigations into how TCM constitutions interact with neurocognitive function are needed.

Entities:  

Keywords:  Elderly Macau individuals; Neurocognitive function; Traditional Chinese medicine constitution

Year:  2021        PMID: 33849623     DOI: 10.1186/s13020-021-00441-2

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  2 in total

1.  A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong.

Authors:  P Y Yeung; L L Wong; C C Chan; Jess L M Leung; C Y Yung
Journal:  Hong Kong Med J       Date:  2014-08-15       Impact factor: 2.227

2.  Relationship Between Traditional Chinese Medicine(TCM)Constitution and TCM Syndrome in the Diagnosis and Treatment of Chronic Diseases.

Authors:  Xiu-Xiu Sang; Zhong-Xia Wang; Shu-Yi Liu; Rui-Lin Wang
Journal:  Chin Med Sci J       Date:  2018-06-30
  2 in total
  4 in total

1.  Relationships Between Traditional Chinese Medicine Constitution and Age-Related Cognitive Decline in Chinese Centenarians.

Authors:  Zhigao Sun; Ping Ping; Yulong Li; Long Feng; Fan Liu; Yali Zhao; Yao Yao; Pei Zhang; Shihui Fu
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

2.  A multi-omics analysis for the prediction of neurocognitive disorders risk among the elderly in Macao.

Authors:  Yan Han; Xingping Quan; Yaochen Chuang; Qiaoxing Liang; Yang Li; Zhen Yuan; Ying Bian; Lai Wei; Ji Wang; Yonghua Zhao
Journal:  Clin Transl Med       Date:  2022-06

3.  A Role of Socioeconomic Status in Cognitive Impairment Among Older Adults in Macau: A Decomposition Approach.

Authors:  Zhuo Zhang; Yonghua Zhao; Ying Bian
Journal:  Front Aging Neurosci       Date:  2022-02-08       Impact factor: 5.750

4.  Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine.

Authors:  Shihua Shi; Fei Wang; Bonan Chen; Jie Pan; Dan Luo; Caixia Pei; Demei Huang; Xiaomin Wang; Yilan Wang; Zherui Shen; Weihao Li; Yongcan Wu; Yacong He; Zhenxing Wang
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.